Acta Orthopaedica, Volume 66, Supplement 266 (1995)

Articles

• Introduction

  Dick Heinegård

  i-i

  Published: 1995-01-01

  • PDF

• Acknowledgements

  Authors Missing

  ii-ii

  Published: 1995-01-01

  • PDF

• Osteoarthritis and molecular markers A rheumatologist's perspective

  Paul Dieppe

  1-5

  Published: 1995-01-01

  • PDF

• Osteoarthrosis-the orthopedic surgeon's perspective

  Eric L Radin

  6-9

  Published: 1995-01-01

  • PDF

• Rheumatoid arthritis-changing theories and treatment modalities

  Leo B A van de Putte, Piet L C M van Riel

  10-13

  Published: 1995-01-01

  • PDF

• Role of biochemical markers in assessment of osteoporosis

  B Lawrence Riggs, Sundeep Khosla

  14-18

  Published: 1995-01-01

  • PDF

• The spatial and temporal expression of cartilage matrix protein illustrates the molecular heterogeneity of cartilage

  Nik Hauser, Paul E Di Cesare, Mats Paulsson

  19-21

  Published: 1995-01-01

  • PDF

• Chondroitin sulphation in human joint tissues varies with age, zone and topography

  Michael T Bayliss, Catherine Davidson, Sandra M Woodhouse, David J Osborne

  22-25

  Published: 1995-01-01

  • PDF

• Pathways of aggrecan processing in joint tissues Implications for disease mechanism and monitoring

  John D Sandy, Anna H K Plaas, Thomas J Koob

  26-32

  Published: 1995-01-01

  • PDF

• Kinetics of release of aggrecan from explant cultures of bovine cartilage from different sources and from animals of different ages

  Mima Z Ilic, Suzanne R Haynes, Gavin M Winter, Christopher J Handley

  33-37

  Published: 1995-01-01

  • PDF

• Cartilage degradation and associated changes in biomechanical and electromechanical properties

  Lawrence J Bonassar, Kimberly A Jeffries, Claribel G Paguio, Alan J Grodzinsky

  38-44

  Published: 1995-01-01

  • PDF

• Stimulation of bone resorption by the kallikrein-kinin system and the coagulation cascade

  Ulf H Lerner

  45-50

  Published: 1995-01-01

  • PDF

• Cartilage-derived morphogenetic proteins Key regulators in chondrocyte differentiation?

  Frank P Luyten

  51-54

  Published: 1995-01-01

  • PDF

• Matrix metalloproteinases and their inhibitors

  Gillian Murphy

  55-60

  Published: 1995-01-01

  • PDF

• Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins

  Larry W Fisher, John T Stubbs, Marian F Young

  61-65

  Published: 1995-01-01

  • PDF

• Molecular mechanisms of bone resorption An update

  Roland Baron

  66-70

  Published: 1995-01-01

  • PDF

• Crosslinking of cartilage matrix protein to aggrecan increases with maturation

  Nik Hauser, Mats Paulsson, Dick Heinegård, Matthias Mörgelin

  71-72

  Published: 1995-01-01

  • PDF

• Distribution of CMP and COMP in human cartilage

  Nik Hauser, Jana Geiss, Michel Neidhart, Mats Paulsson, Hans Jörg Häuselmann

  72-73

  Published: 1995-01-01

  • PDF

• Differential display reverse transcription PCR reveals IL-1 induced gene expression patterns in human articular chondrocytes

  Daniel Margerie, Johannes Flechtenmacher, Frank Büttner, Alfred Karbowski, Eckart Bartnik

  74-75

  Published: 1995-01-01

  • PDF

• Concentration and size distribution of IGF-I in human normal and osteoarthritic synovial fluid and cartilage

  Rosa Schneiderman, Nahum Rosenberg, Yehuda Hiss, Phillip Lee, Alice Maroudas

  75-76

  Published: 1995-01-01

  • PDF

• Characterization of osteoadherin—a novel, cell binding keratan sulfate proteoglycan from bone

  Mikael Wendel, Yngve Sommarin, Dick Heinegård

  77-77

  Published: 1995-01-01

  • PDF

• Bone sialoprotein distribution in guinea pig osteoarthritis

  Edin de Bri, Finn P Reinholt, Dick Heinegård, Silwa Mengarelli-Widholm, Olle Svensson

  78-79

  Published: 1995-01-01

  • PDF

• Differential release of molecular markers in joint disease

  Tore Saxne

  80-83

  Published: 1995-01-01

  • PDF

• The role of molecular markers to monitor disease, intervention and cartilage breakdown in osteoarthritis

  L Stefan Lohrnander, Harald Roos, Leif Dahlberg, Michael W Lark

  84-87

  Published: 1995-01-01

  • PDF

• Collagen II turnover in joint diseases

  A Robin Poole, Fred Nelson, Anthony Hollander, Agnes Reiner, Isabelle Pidoux, Mirela Ionescu1

  88-91

  Published: 1995-01-01

  • PDF

• Aggrecan degradation in osteoarthritis and rheumatoid arthritis

  Michael W Lark, Ellen K Bayne, L Stefan Lohmander

  92-97

  Published: 1995-01-01

  • PDF

• MMP-8 (neutrophil collagenase) mRNA and aggrecanase cleavage products are present in normal and osteoarthritic human articular cartilage

  Ada A Cole, Klaus E Kuettner

  98-102

  Published: 1995-01-01

  • PDF

• Keratan sulfate in body fluids in joint disease

  Eugene J-M A Thonar, Koichi Masuda, Hans J Häuselmann, Daniel Uebelhart, Mary Ellen Lenz, Daniel H Manicourt

  103-106

  Published: 1995-01-01

  • PDF

• Changes in chondroitin sulphate structure induced by joint disease

  Tim Hardingham

  107-110

  Published: 1995-01-01

  • PDF

• High levels of aggrecan aggregate components are present in synovial fluids from human knee joints with chronic injury or osteoarthrosis

  Anthony Ratcliffe, Ronald P Grelsamer, Howard Kiernan, Fatemeh Saed-Nejad, Denise Visco

  111-115

  Published: 1995-01-01

  • PDF

• Hyaluronan in inflammatory joint disease

  Torvard C Laurent, J Robert E Fraser, Ulla B G Laurent, Anna Engström-Laurent

  116-120

  Published: 1995-01-01

  • PDF

• Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis

  Bruce Caterson, Clare E Hughes, Peter Roughley, John S Mort

  121-124

  Published: 1995-01-01

  • PDF

• Upregulation of type X collagen expression in osteoarthritic cartilage

  Klaus von der Mark, Svenja Frischholz, Thomas Aigner, Frank Beier, Jutta Belke, Silke Erdmann, Harald Burkhardt

  125-129

  Published: 1995-01-01

  • PDF

• Detection and monitoring of progressive degeneration of osteoarthritic cartilage by MRI

  Jenny A Tyler, Paul J Watson, Hwee-Ling Koh, Nicholas J Herrod, Matthew Robson, Laurance D Hall

  130-138

  Published: 1995-01-01

  • PDF

• Dynamics of articular joints visualised by MRI: Joint flexion, cartilage-compression and solute-perfusion

  Laurance D Hall, Alan E Fischer, Michael J Nolan, T Adrian Carpenter, Jenny A Tyler

  139-141

  Published: 1995-01-01

  • PDF

• Cartilage proteins in serum and synovial fluid as markers for cartilage degradation

  Michel Neidhart, Nik Hauser, Jana Geiss, Paul E Di Cesare, Mats Paulsson, Beat A Michel, Hansjörg Häuselmann

  142-144

  Published: 1995-01-01

  • PDF

• Changes in serum levels of cartilage and bone markers in early osteoarthritis of the knee

  Ingemar F Petersson, Torsten Boegård, Jan Dahlström, Björn Svensson, Dick Heinegård, A Robin Poole, Mirela Lonescu, Tore Saxne

  144-145

  Published: 1995-01-01

  • PDF

• Elevation of plasma hyaluronan and urinary pyridinoline in mouse collagen induced arthritis

  Ronald L Goldberg, Vishwas S Ganu, Bernard Kotyuk, John R Doughty, Anil Raychaudhuri

  145-147

  Published: 1995-01-01

  • PDF

• Intra-articular and circulating levels of type I and III collagen markers in inflammatory and degenerative joint disease

  Michael Stoltenberg, Mikkel Østergaard, Kim Hørslev-Petersen, Peter Kryger, Lb Lorenzen

  147-148

  Published: 1995-01-01

  • PDF

• An examination of some molecular markers in blood and urine for discriminating patients with osteoarthritis from healthy individuals

  Ivan G Otterness, Rupert O Zimmerer, Archie C Swindell, A Robin Poole, Tore Saxne, Dick Heinegård, Mirela Lonescu, Ethan Weiner

  148-150

  Published: 1995-01-01

  • PDF

• Evolution of a matrix metalloproteinase assay to assess inhibitor potency and selectivity

  James Trzaskos, Michael Pratta, Dianna Blessington, Elizabeth Arner, Jean Williams, John Giannaras, Robert A Copeland, Randi Dowling, Diane Lombardo, Carl Decicco

  150-151

  Published: 1995-01-01

  • PDF

• Development of a convenient and sensitive assay for matrix metalloproteinase enzyme activity in synovial fluid samples using fluorigenic peptides

  Johan M te Koppele, Bob Beekman, Willem Bloemhoff, Jan W Drijfhout

  151-152

  Published: 1995-01-01

  • PDF

• Interleukin-1 induces aggrecanase-mediated cleavage in human articular cartilage without up-regulating stromelysin or glycosaminoglycan release

  Elizabeth C Arner, Theresa M Di Meo, Michael A Pratta, Micky D Tortorella

  153-154

  Published: 1995-01-01

  • PDF

• Immunogenetic profiles correlate with pro-MMP expression in rheumatoid arthritis

  Helmut Fenner, David Taylor, Manfred Schattenkirchner, Gerd Folkers, Stefan Zueger

  154-155

  Published: 1995-01-01

  • PDF

• The TNF-MMP-matrix network and serum markers for cartilage synthesis and degradation

  Helmut Fenner, David Taylor, Gerd Follkers, Stefan Zueger

  156-157

  Published: 1995-01-01

  • PDF

• Measurement of chondroitin sulphate disaccharides in pathological joint fluids

  Samantha Lewis, Margot Crossman, Joanne Flannelly, Michael Doherty, Michael Bayliss, Roger Mason

  157-158

  Published: 1995-01-01

  • PDF

• Characterization of proteoglycan populations separated by agarose electrophoresis

  Sven Björnsson

  158-159

  Published: 1995-01-01

  • PDF

• Regulation of hyaluronan synthesis and the interaction of hyaluronan with cells

  Paraskevi Heldin, Tomas Asplund, Priit Teder, Masanobu Suzuki, Dionisios Vrochides, Vasilios Papanikolaou, Håkan Pertoft

  160-162

  Published: 1995-01-01

  • PDF

• Localization of hyaluronan and the hyaluronan receptor ICAM-1 in rheumatoid synovia—a histochemical study

  Stefan Gustafson, Anna Engström-Laurent, Tarja Wikström, Ann-Marie Gustafson

  162-164

  Published: 1995-01-01

  • PDF

• Diagnostic approaches to connective tissue diseases

  S Mitchell Seyedin

  165-165

  Published: 1995-01-01

  • PDF

• The specificity of collagen cross-links as markers of bone and connective tissue degradation

  David R Eyre

  166-170

  Published: 1995-01-01

  • PDF

• Collagen crosslinks in metabolic bone disease

  Simon P Robins

  171-175

  Published: 1995-01-01

  • PDF

• Biochemical markers of bone turnover

  Pierre D Delmas

  176-182

  Published: 1995-01-01

  • PDF

• Collagen propeptides as indicators of collagen assembly

  Juha Risteli, Seija Niemi, Saila Kauppila, Jukka Melkko, Leila Risteli

  183-188

  Published: 1995-01-01

  • PDF

• The tartrate-resistant purple acid phosphatase of bone osteoclasts—a protein phosphatase with multivalent substrate specificity and regulation

  Göran Andersson, Barbro Ek-Rylander

  189-194

  Published: 1995-01-01

  • PDF

• Bone changes in metabolic bone disease

  Erik Fink Eriksen, Bente Langdahl

  195-201

  Published: 1995-01-01

  • PDF

• Urinary collagen crosslinks to monitor bone and cartilage degradation in collagen-induced arthritis in rhesus monkeys

  Johan M te Koppele, Bert A't Hart

  202-203

  Published: 1995-01-01

  • PDF

• Determination of bone alkaline phosphatase isoforms in serum by a new high-performance liquid chromatography assay in patients with metabolic bone disease

  Per Magnusson, Owe Löfman, Göran Toss, Lasse Larsson

  203-204

  Published: 1995-01-01

  • PDF

• Validating markers in osteoarthritis

  David T Felson

  205-207

  Published: 1995-01-01

  • PDF

• Fractures in the elderly

  Karl-Göran Thorngren

  208-210

  Published: 1995-01-01

  • PDF

• Molecular markers for joint and skeletal diseases Notes from the general discussion

  Paul Dieppe

  211-212

  Published: 1995-01-01

  • PDF